Aridis Pharmaceuticals poised for readout of top-line data for its flagship AR-105 treatment in 3Q - Proactive Investors USA & Canada

Aridis Pharmaceuticals poised for readout of top-line data for its flagship AR-105 treatment in 3Q  Proactive Investors USA & Canada

Aridis Pharmaceuticals Inc (NASDAQ:ARDS) - AR-105 is a treatment for ventilator-associated pneumonia caused by a variety of Pseudomonas aeruginosa, ...



Comments

Popular posts from this blog

Rashes that look like scabies: Causes, symptoms, and treatment - Medical News Today

Urinary Tract Infection (UTI): Causes, Symptoms & Treatment - Cleveland Clinic

Symtuza: Uses, side effects, alternatives, and more - Medical News Today